ICA-01TB

N/A

Report date: 2024/10/22 17:58:18

Base Information

Drug NameICA-01TB
Drug Alias NameICA01TB
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesSuzhou Aika Liyuan Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Aika Liyuan Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A